chr12-102958295-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004316.4(ASCL1):c.51G>T(p.Gln17His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,479,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004316.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASCL1 | NM_004316.4 | c.51G>T | p.Gln17His | missense_variant | 1/2 | ENST00000266744.4 | |
PAH | NM_001354304.2 | c.-196C>A | 5_prime_UTR_variant | 1/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASCL1 | ENST00000266744.4 | c.51G>T | p.Gln17His | missense_variant | 1/2 | 1 | NM_004316.4 | P1 | |
PAH | ENST00000551337.5 | c.-196C>A | 5_prime_UTR_variant | 1/5 | 3 | ||||
PAH | ENST00000547319.1 | n.116C>A | non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151980Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000115 AC: 10AN: 87152Hom.: 0 AF XY: 0.000160 AC XY: 8AN XY: 50054
GnomAD4 exome AF: 0.0000301 AC: 40AN: 1327864Hom.: 0 Cov.: 29 AF XY: 0.0000428 AC XY: 28AN XY: 654804
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151980Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | The c.51G>T (p.Q17H) alteration is located in exon 1 (coding exon 1) of the ASCL1 gene. This alteration results from a G to T substitution at nucleotide position 51, causing the glutamine (Q) at amino acid position 17 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at